Dr. Fuad Ahmed

Consultant General Surgeon, Iraq

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Prof. Dr. Basil Ammori

Consultant Laparoscopic, Bariatric, General, Gastrointestinal & Hepatobiliary Surgery , UK

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Highlights

• Laparoscopic bariatric surgery (sleeve and gastric bypass)
• Laparoscopic gastric band placement and removal of gastric band
• Intragastric balloon placement and removal
• Laparoscopic gastroesophageal reflux surgery (Nissen fundoplication)
• Laparoscopic cholecystectomy (gallbladder surgery)
• Laparoscopic bile duct exploration
• Laparoscopic hepatobiliary and pancreatic surgery (HPB surgery, hepato-pancreato-biliary surgery)
• Laparoscopic liver resection
• Laparoscopic pancreas resection
• Laparoscopic pancreas pseudocyst surgery
• Laparoscopic colon resection for cancer
• Laparoscopic gastrectomy for cancer
• Laparoscopic adrenalectomy
• Laparoscopic splenectomy
• Laparoscopic hernia surgery
• Laparoscopic appendectomy

Ms. Heba Ezzi

Clinical Dietitian, Syria

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Ms. Lama Saleem

Clinical Dietitian, Jordan

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Ms. Ruqsar Rahman

Clinical Dietitian, India

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Highlights

• Invitro study on the Relation of Anti-Diabetic Properties between Cassia Auriculata and Musa Paradiscca
• Retrospective Study on the Pediatric Population and Lactating Mothers

Dr. Mahmood Al-Majmuei

Consultant Rheumatology, New Zealand

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Dr. Nagwa Mahmoud Mossalem

Consultant Rheumatology , Egypt

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Dr. Sadir Al Rawi

Consultant Surgical Oncology, USA

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Highlights

• Surgical oncology
• Upper GI surgeries
• Head and neck oncology
• Minimal invasive oncology
• Breast oncology
• Colorectal oncology
• Heated chemoperfusion
• Oncology research

Dr. Hassan Jaafar

Consultant Medical Oncology, Lebanon

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Highlights

• Bilateral breast involvement in acute myelogenous leukaemia, Mammographic and ultrasound findings. The European Radiology 2000; 10 (6):1031
• Recurrence of thrombocytopenia in previously diagnosed thrombotic thrombocytopenia purpura (TTP) does not always mean TTP recurrence. Annals Saudi med. 2003 may-jul;23(3-4):228-9
• Strongyloides hyper-infection causing life-threatening gastrointestinal bleeding. World J Gastroenterol. 2006 Oct 21;12(39):6401-4
• Metastatic Castrate Resistant Prostate Cancer: Current Strategies of Management in the Middle East. Critical Reviews in Oncology/Hematology" Journal 2013 Nov 8.pii: s1040-8428(13)00229-1
• Impact of Oncotype DX Testing on Adjuvant Treatment Decisions in Patients with Early Breast Cancer: A Single-Center Study in the United Arab Emirates Asia Pac J Clin Oncol. 2014 Sep 22. doi: 10.1111/ajco.12259.
• Everolimus with endocrine therapy as a treatment option in ER + MBC failing at least one line of endocrine therapy: a single institute experience, Pan Arab Journal of Oncology vol 7; issue 2, June 2014.
• A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5?fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer.Cancer Chemother Pharmacol DOI 10.1007/s00280-015-2906-5
• Epidemiology of breast cancer in the United Arab Emirates – a multi-Ethnic population Emirates Oncology Journal EOJ 2 November 2015
• Patterns of epidermal growth factor receptor mutation in non-small-cell lung cancers in the Gulf region. Molecular and Clinical Oncology 3: 1371-1374, 2015
• Supportive care needs of multicultural patients with cancer in the United Arab Emirates E-cancer medical science. 2018 May 29;12:838 doi: 10.3332/ecancer.2018.838.eCollection 2018.
• The study of druggable targets in nonsquamous non-small-cell lung cancer in the Middle East and North Africa Journal of Immunotherapy and Precision Oncology 2 (1), 4-7
• Patterns of diagnostic procedures for lung cancer pathology in the Middle East and North Africa Journal of thoracic disease 11 (12), 5162
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. The Gulf Journal of Oncology 1 (32), 71-87
• Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries RTGI Group World journal of clinical cases 8 (3), 487
• 151P Prevalence of Anaplastic Lymphoma Kinase (ALK)+ Non-Small Cell Lung Cancer (NSCLC) in the Middle East and North Africa (MENA), Annals of Oncology 31, S299
• Epidermal growth factor receptor (EGFR) positive non-small-cell lung carcinoma (NSCLC) patients in the Gulf region: current status, challenges, and call for action Journal of Cancer Prevention & Current Research 11 (Issue 5 - 2020), (5):130?134
• Management guidelines for stageIIInon-small cell lung cancer, Critical Reviews in Oncology/Hematology 157, 103144
• Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations, Clin. Pract. 2021, 11, 671–678.
• Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer in the Middle East and North Africa, JCO Global Oncol 7:1556-1563.2021 by American Society of Clinical Oncology
• Other several articles and published works

Prof. Humaid Obaid bin Harmal Al Shamsi

Consultant & Director Oncology Services, VPS , UAE

Burjeel Multispecialty Hospital, Abu Dhabi Municipality

Highlights

• Humaid Al-Shamsi, Siefker-Radtke A, Czerniak B, Dinney C, Millikan RE. Uncommon Cancers of the Bladder. Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG, Mayer IA. John Wiley and Son, 2016. Textbook of Uncommon Cancer, 5th ed. Ed(s).
• Handbook of Healthcare in the Arab World. Springer, Cham. Palliative Care in the United Arab Emirates (UAE). Nijhawan N.A., Al-Shamsi H.O. (2021)
• Oncology Care in the UAE. In: Laher I. (eds). Laher I. (eds).Abu-Gheida I., Nijwahan N., Al-Shamsi H.O. (2020). Handbook of Healthcare in the Arab World. Springer, Cham.
• Successful Vaccination of Patients with History of Severe Anaphylactic Reaction with Pfizer-Biotech COVID-19 Vaccine. Humaid, O. Al-Shamsi, Eric A Coomes (2021) Journal of Oncology Research Review & Reports. SRC/JONRR-125.
• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries’ Patients: A Cross-Sectional Study of 96 Cases. Al-Shamsi, H. O., Alzaabi, A. A., Afrit, M., Abu-Gheida, I., & Musallam, K. M. (2021). Journal of Oncology Research Review & Reports. SRC/JONRR-133, 3.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Al-Shamsi, H., Azribi, F., Abu-Gheida, I., Jaafar, H., & Razek, A. A. (2021). Journal of Oncology Research Review & Reports. SRC/JONRR-137, 3.
• The Burden of Gynecologic Cancers in the UAE. Humaid O Al-Shamsi, Faryal Iqbal, Mohd Subhi Al-Saad, Priyanka Ashish Dhemre, Fady Georges Hachem, et al. (2021) Journal of Oncology Research Review & Reports. SRC/JONRR-147.
• Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature. Bukhari N, Alshangiti A, Tashkandi E, Algarni M, Al-Shamsi HO, Al-Khallaf H. Clinics and Practice. 2021; 11(3):467-471.
• The decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates-A retrospective study. Azhar, Malik, Faisal Aziz, Salama Almuhairi, Mohammad Alfelasi, Ali Elhouni, Rizwan Syed, Humaid O. Al-Shamsi, and Khaled M. Aldahmani. Annals of Medicine and Surgery 64 (2021): 102203.
• Higher and Increasing Incidence of Cancer between the Age of 20-49 Years in the UAE Population; A focus Analysis of the UAE National Cancer Registry Data 2015-2017. Humaid, O. Al-Shamsi, Eric A Coomes (2021) Journal of Oncology Research Review & Reports. SRC/JONRR-127, 3.
• A Strong Beliefs and Soft Evidence Underlying Mammography Surveillance Recommendations in Breast Cancer Survivors: A Study in Reflexive Science and Decision-Making. Humaid, O. Al-Shamsi, Sadir Alrawi, Ahmed S. Abdulsamad, Nuhad K. Ibrahim (2021) Journal of Oncology Research Review & Reports. SRC/JONRR-131, 3.
• One-stop-shop for cancer screening: A model for the future." (2021): 10554-10554. Bernstein, Ezra, Shiran Shapira, Shahar Lev-Ari, Ari Leshno, Udi A. Sommer, Lior Galazan, Humaid O. Al-Shamsi, et al.
• Impact of COVID 19 pandemic on the psychological wellbeing of oncology clinicians in MENA (the Middle East and North Africa) region. Latif, M.F., Azam, F., Tirmazy, S.H., Bashir, S., Ibnshamsah, F., Al Selwi, W.M., Bukhari, N., Alwbari, A., Alshangiti, A., Gabsi, A., and Al-Shamsi, H.O., 2021.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Al-Shamsi, H., Darr, H., Abu-Gheida, I., Ansari, J., McManus, M. C., Jaafar, H., ... & Al-Khatib, F. (2020). The Gulf Journal of Oncology, 1(32), 71-87.
• Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. Al-Shamsi, H. O., Coomes, E. A., & Alrawi, S. (2020). JAMA oncology, 6(10), 1627-1628. Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates. Al-Shamsi, H. O., Coomes, E. A., Aldhaheri, K., & Alrawi, S. (2020). Serial JAMA oncology. doi:10.1001/jamaoncol.2020.5745.
• Rethinking Cancer Screening and Diagnosis During the Covid-19 Pandemic. Humaid O. Al-Shamsi (2020) Journal of Oncology Research Review & Reports. SRC/JORRR/110.
• Early Onset Colorectal Cancer in the United Arab Emirates, Where do we Stand? Humaid O. Al-Shamsi., et al. Acta Scientific Cancer Biology 4.11 (2020): 24-27.
• Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients. Abdel-Wahab, R., Hassan, M.M., George, B., Pestana, R.C., Xiao, L., Lacin, S., Yalcin, S., Shalaby, A.S., Al-Shamsi, H.O., Raghav, K. and Wolff, R.A., 2020 Oncology, 98(12), pp.836-846.
• Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism-a consensus report by the emirates oncology task force. Al-Shamsi, H. O., Abu-Gheida, I., Rana, S. K., Nijhawan, N., Abdulsamad, A. S., Alrawi, S., ... & McManus, M. C. (2020). BMC Cancer, 20(1), 1-10.
• A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. Oncologist. 2020 Jun;25(6):e936-e945.
• Outcomes and Impact of a Universal COVID-19 Screening Protocol for Asymptomatic Oncology Patients. Al Shamsi, H., R. Iskanderian, R., Karmstaji, A., Kamal Mohamed, B., Alahmed, S., H. Masri, M.R. Grobmyer, S. (2020). The Gulf Journal of Oncology, (34), 162-167.
• Evolution of Cancer Care in Response to the COVID?19 Pandemic. Coomes, E. A., Al?Shamsi, H. O., Meyers, B. M., Alhazzani, W., Alhuraiji, A., Chemaly, R. F., & Xie, C. (2020). The oncologist, 25(9), e1426-e1427.
• Authors Reply Oncological surgery during COVID-19 pandemic: The need for deep and lasting measures. Al-Shamsi HO et al., Cholangiocarcinoma with FGFR genetic aberrations: a unique clinical phenotype. Jain, A., Borad, M.J., Kelley, R.K., Wang, Y., Abdel-Wahab, R., Meric-Bernstam, F., Baggerly, K.A., Kaseb, A.O., Al-Shamsi, H.O., Ahn, D.H. and DeLeon, T., 2018. JCO Precision Oncology, 2, pp.1-12.
• Patient selection and risk factors in the changing treatment landscape of metastatic renal cell carcinoma, Ehab Abdou, Ravi M Pedapenki, Mohamed Abouagour, Abdul R Zar, Emad Anwar, Dalia Elshourbagy, Humaid Al-Shamsi & Enrique Grande (2020). Expert Review of Anticancer Therapy, Sep 15th, 2020.
• Authors Reply: How to manage febrile neutropenia during the COVID pandemic? In response to “A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic,”. Al-Shamsi HO et al. The Oncologist
• Virtual management of cancer patients in the era of COVID-19 pandemic. Tashkandi, E., Zeeneldin, A., AlAbdulwahab, A., Elemam, O., Elsamany, S., Jastaniah, W., & Al-Shamsi, H. (2020). J Med Internet Res [Internet].
• Mammography screening for breast cancer—the UK Age trial. Al-Shamsi, H. O. (2020). The Lancet Oncology, 21(11), e505.
• COVID-19 Vaccination for Cancer Patients, What Oncologists and Cancer Patients Need to Know? Humaid O. Al-shamsi (2020). Journal of Oncology. Research Review & Reports. SRC/JONRR-114.
• Anterior Mediastinal Mass: A Rare Presentation of Thyroid Mass Compressing Mediastinal Structures. Humaid O. Al-shamsi (2020). Journal of Oncology. Research Review & Reports. SRC/JORRR-113.
• Tele-Oncology: An Emerging Technology in Developing Countries during the COVID-19 Pandemic. Atlal M. Abusanad and Humaid O. Al-Shamsi. New Emirates Medical Journal (2020) 1: 1.
• 1737P National approaches to managing cancer care: Responses of countries in the MENA region to COVID-19 pandemic. Benbrahim, Z., Al Asiri, M., Al Bahrani, B., AlNassar, M. A., Al-Shamsi, H. O., Bounedjar, A., & Labidi, S. (2020). Annals of Oncology, 31, S1016.
• Malignant Peritoneal Mesothelioma Following Wilms’ Tumor in a Horse-Shoe Kidney, A Case Report and Review of Literature. Abdulsamad, A. S., Inam, A., Oner, M., Darr, H., Madi, T., Alrawi, S. J., & Al-shamsi, H. O. (2019). Cancer Therapy & Oncology International Journal, 13(2), 66-71. Palliative Care in the United Arab Emirates, a Desperate Need. Al-Shamsi HO , Tareen M (2018). Palliat Med Care 5(3): 1-4.
• Chasing the cure around the globe: medical tourism for Cancer care from developing countries. Al-Shamsi, H. O., Al-Hajeili, M., & Alrawi, S. (2018). Journal of Global Oncology.
• Expatriates with a cancer diagnosis in the United Arab Emirates, hanging on the edge. Al-Shamsi, H. O. (2018). J Cancer Prev Curr Res, 9(5), 257-258.
• Breast cancer screening in the United Arab Emirates: is it time to call for a screening at an earlier age. Al-Shamsi, H. O., & Alrawi, S. (2018). J Cancer Prev Curr Res, 9(3), 123-126.
• Awareness, understanding, attitude, and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries. Al-Shamsi, H. O., Tashkandi, E., Bukhari, N., Al Farsi, A., Alnajjar, A., Alhuraiji, A., ... & Alrawi, S. (2018). Gulf J Oncol, 1, 45-51.
• Update on the treatment of metastatic urothelial carcinoma. Bukhari, N., Al-Shamsi, H. O., & Azam, F. (2018). The Scientific World Journal, 2018.
• Long-Standing Course of Disease in a Patient with Muir-Torre Syndrome. Khan, M., & Al-Shamsi, H. O. (2018).
• Non-V600BRAF mutations define a clinically distinct molecular subtype of metastatic colorectal cancer. Jones, J. C., Renfro, L. A., Al-Shamsi, H. O., Schrock, A. B., Rankin, A., Zhang, B. Y., & Grothey, A. (2017). Journal of Clinical Oncology, 35(23), 2624.
• Utility of the Edmonton Frail Scale in identifying frail elderly patients during treatment of colorectal cancer. Meyers BM, Humaid O. Al-Shamsi, Rask S, Yelamanchili R, Phillips CM, Papaioannou A, Pond GR, Jeyabalan N, Zbuk KM, Dhesy-Thind SK. J Gastrointest Oncol 2017;8(1):32-38. Corrigendum to “The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer.” Al-Shamsi, H. O., Lau, A. N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., Papaioannou, A. (2017). Journal of oncology, 2017.
• Natural history of T1N0M0 hepatocellular carcinoma: Large-scale study in the United States. Al-Shamsi, H. O., Abdel-Wahab, R., Hassan, M. M., Shalaby, A. S., Dahbour, I., Lacin, S. & Kaseb, A. O. (2017). Oncology, 93(4), 233-242. Association of elevated alpha-1 antitrypsin with advanced clinicopathologic features of hepatocellular carcinoma. Abdel-Wahab, R., Hassan, M., Wolff, R. A., Lacin, S., Al-Shamsi, H. O., Raghav, K. P. S., ... & Kaseb, A. O. (2017). BRCA-associated protein one mutant cholangiocarcinoma: an aggressive disease subtype. Al-Shamsi, H. O., Anand, D., Shroff, R. T., Jain, A., Zuo, M., Conrad, C., ... & Javle, M. M. (2016). Journal of Gastrointestinal Oncology, 7(4), 556. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience. Al-Shamsi HO, Fahmawi Y, Dahbour I, Tabash A, Rogers JE, Mares JE, Blum MA, Estrella J, Matamoros A Jr, Sagebiel T, Devine CE, Bagwell BD, Lin QD, Das P, Ajani JA. J Gastrointest Oncol. 2016 Aug;7(4):499- 505.
• Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: Determination of frequency and distribution pattern. Humaid O. Al-Shamsi, Robert A. Wolff. J Gastrointest Oncol 2016;7(6):882-902.
• The addition of bevacizumab to neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer more not necessarily better. Al-Shamsi, H. O., & Ibrahim, N. K. (2016). Translational Cancer Research, 5, S694-S696
• The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases. Al-Shamsi, H. O., Alzahrani, M., & Wolff, R. A. (2016). Journal of gastrointestinal oncology, 7(3), E45.
• Prognostic effect of angiotensin-converting-enzyme inhibitors (ACEI) and diuretics in patients with pancreatic cancer. Al-Shamsi, H. O., Shalaby, A., Dar, A. Y., Hassan, M., Wolff, R. A., & Li, D. (2016).
• P-114 A phase II trial of bevacizumab and erlotinib as second-line therapy for advanced hepatocellular carcinoma. Kaseb, A., Al-Shamsi, H., Morris, J., Iwasaki, M., Xiao, L., Abdelwahab, R., ... & Wolff, R. (2015). Annals of Oncology, 26(suppl_4).
• A case report is a case report for chronic abdominal pain secondary to mesenteric panniculitis treated successfully with endoscopic ultrasonography-guided celiac plexus block. Alhazzani, W., Al-Shamsi, H. O., Greenwald, E., Radhi, J., & Tse, F. (2015). World journal of gastrointestinal endoscopy, 7(5), 563.
• Extended RAS testing in metastatic colorectal cancer—Refining the predictive molecular biomarkers. Al-Shamsi, H. O., Alhazzani, W., & Wolff, R. A. (2015). Journal of gastrointestinal oncology, 6(3), 314.
• Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer. Al-Shamsi, H. O., Kee, B. K., Tetzlaff, M. T., & Wolff, R. A. (2015). Journal of gastrointestinal oncology, 6(3), E40.
• HER2/neu-directed therapy for biliary tract cancer. Milind Javle, Chaitanya Churi, HyunSeon C. Kang, Rachna Shroff, Filip Janku, Rakesh Surapaneni, Mingxin Zuo, Christian Barrera, AlShamsi H, Sunil Krishnan, Lopa Mishra, Robert A. Wolff, Ahmed O. Kaseb, Melanie B. Thomas, and Abby B. Siegel. Journal of Hematology & Oncology 2015, 8:58.
• Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil, and irinotecan (FOLFIRI) plus bevacizumab. Al-Shamsi HO, Al Farsi A, Anjum M, Shen H, Zbuk K, Cook RJ, Linkins LA, Major P. J Gastrointest Oncol 2015;6(3):274-279. doi: 10.3978/j.issn.2078-6891.2015.025.
• A phase II trial of bevacizumab and erlotinib as second-line therapy for advanced hepatocellular carcinoma. Kaseb, A. O., Al-Shamsi, H. O., Morris, J., Iwasaki, M., Xiao, L., Abdel-Wahab, R., ... & Wolff, R. A. (2015).
• Natural History of T1N0M0 Hepatocellular carcinoma: Large scale study in the United States. Al-Shamsi, H. O., Abdel-Wahab, R., Hassan, M., Botrus, G., Shalaby, A. S., Wolff, R. A., & Kaseb, A. O. (2015). HER2/neu-directed therapy for biliary tract cancer. Javle, M., Churi, C., Kang, H.C., Shroff, R., Janku, F., Surapaneni, R., Zuo, M., Barrera, C., Alshamsi, H., Krishnan, S. and Mishra, L., 2015. Journal of hematology & oncology, 8(1), pp.1-9.
• HER2/neu-directed therapy for biliary tract cancer. Al-Shamsi, H. O., Barrera, C. D., Surapaneni, R., Kang, H., Shroff, R. T., Janku, F., & Javle, M. M. (2015).
• Cochrane systematic review and meta-analysis of adjuvant therapy for stage II colon cancer. Meyers, B. M., Al-Shamsi, H. O., & Figueredo, A. T. (2015).
• A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration-resistant prostate cancer. Clayton R, Wu J, Heng DY, North SA, Emmenegger U, Hotte S, Chi K, Zielinski R, Al-Shamsi H, Chen L, Eigl B. Can Urol Assoc J. 2014 Sep;8(9-10):E583-90. doi: 10.5489/cuaj.1891.
• Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment. Al-Shamsi HO, Al Farsi A, Ellis PM. Clin Lung Cancer. 2014 Jul;15(4):274-80.
• A multicenter population-based experience with abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (mCRPC)." (2013): 113-113. Clayton, Ravinder, Daniel Yick Chin Heng, Jackson SY Wu, Rob Zielinski, Scott A. North, Urban Emmenegger, Sebastien J. Hotte, Humaid Obaid Al-Shamsi, Leo Chen, and Bernhard J. Eigl.
• Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab. Al-Shamsi, H. O., Anjum, M., Al Farsi, A. M., Shen, H., Cook, R. J., Linkins, L. A., & Major, P. (2013).
• Rapid assessment of frailty before treatment of elderly colorectal cancer patients. Dhesy-Thind, S. K., Meyers, B. M., Al-Shamsi, H. O., Papaioannou, A., Zbuk, K. M., & Pond, G. R. (2013).
• The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer. Al-Shamsi, H. O., Lau, A. N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., ... & Papaioannou, A. (2012). Journal of oncology, 2012.
• III NSCLC: How many patients are suitable for radical treatment approaches?. Al-Shamsi, H. O., & Ellis, P. M. (2012).
• Utilization of Radiation Therapy in Metastatic Castration-Resistant Prostate Cancer Following the Introduction of Abiraterone into Clinical Oncology Practice. Clayton, R., Wu, J., Heng, D. Y., North, S. A., Emmenegger, U., Al-Shamsi, H. O., ... & Eigl, B. J. (2012). International Journal of Radiation Oncology, Biology, Physics, 84(3), S361-S362.
• Utility of the Edmonton Frail Scale (EFS) in identifying frail elderly patients during colorectal cancer (CRC) treatment. Al-Shamsi, H. O., Lau, A. N., Malik, K., Alamri, A., Ioannidis, G., Corbett, T., ... & Papaioannou, A. (2012). Journal of oncology, 2012.
• Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast Cancer. Meyers, B. M., Yelamanchili, R., Rask, S., Al-Shamsi, H. O., Phillips, C. M., Papaioannou, A., ... & Dhesy-Thind, S. K. (2012). Humaid O. Al-Shamsi, Abu-Gheida I, Abdulsamad AS, AlAwadhi A, Alrawi S, Musallam KM, Arun B, Ibrahim NK. Oncologist. 2021.